Guangzhou LBP Medicine Science & Technology Past Earnings Performance
Past criteria checks 0/6
Guangzhou LBP Medicine Science & Technology's earnings have been declining at an average annual rate of -21.6%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 8.4% per year. Guangzhou LBP Medicine Science & Technology's return on equity is 2%, and it has net margins of 6.5%.
Key information
-21.6%
Earnings growth rate
-27.8%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 8.4% |
| Return on equity | 2.0% |
| Net Margin | 6.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit
Nov 06
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29Recent updates
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit
Nov 06Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon
Sep 30Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%
Apr 23Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings
Mar 09Revenue & Expenses Breakdown
How Guangzhou LBP Medicine Science & Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 495 | 32 | 281 | 48 |
| 30 Jun 24 | 514 | 38 | 280 | 57 |
| 31 Mar 24 | 508 | 40 | 272 | 59 |
| 31 Dec 23 | 497 | 40 | 263 | 63 |
| 30 Sep 23 | 488 | 37 | 263 | 65 |
| 30 Jun 23 | 476 | 26 | 274 | 64 |
| 31 Mar 23 | 478 | 31 | 272 | 65 |
| 31 Dec 22 | 507 | 43 | 265 | 67 |
| 30 Sep 22 | 486 | 49 | 265 | 58 |
| 30 Jun 22 | 469 | 64 | 245 | 62 |
| 31 Mar 22 | 460 | 73 | 237 | 55 |
| 31 Dec 21 | 439 | 80 | 234 | 46 |
| 30 Sep 21 | 438 | 93 | 229 | 45 |
| 30 Jun 21 | 443 | 103 | 229 | 32 |
| 31 Mar 21 | 436 | 102 | 222 | 30 |
| 31 Dec 20 | 375 | 85 | 192 | 28 |
| 30 Sep 20 | 370 | 80 | 185 | 26 |
| 30 Jun 20 | 344 | 75 | 172 | 25 |
| 31 Mar 20 | 323 | 68 | 171 | 23 |
| 31 Dec 19 | 355 | 74 | 190 | 22 |
| 31 Dec 18 | 306 | 61 | 165 | 16 |
| 31 Dec 17 | 260 | 48 | 142 | 15 |
| 31 Dec 13 | 143 | 38 | 57 | 0 |
Quality Earnings: 688393 has a large one-off gain of CN¥3.1M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 688393's current net profit margins (6.5%) are lower than last year (7.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688393's earnings have declined by 21.6% per year over the past 5 years.
Accelerating Growth: 688393's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688393 had negative earnings growth (-12.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688393's Return on Equity (2%) is considered low.